Other

Contingent consideration

Thermo Fisher Scientific Contingent consideration increased by 950.0% to $168.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026May 1, 2026
Metric ID: other_business_combination_contingent_consideration_liab_781c87

Historical Data

2 periods
 Q4 '25Q1 '26
Value$16.00M$168.00M
QoQ Change—+950.0%
Range$16.00M – $168.00M

Frequently Asked Questions

What is Thermo Fisher Scientific's contingent consideration?
Thermo Fisher Scientific (TMO) reported contingent consideration of $168.00M in Q1 2026.